FormDSignal
40

Bioventrix raises $3M for medical device development in Massachusetts

Company raise · Raising · MANSFIELD, MA · Form D filed 2026-10-08

Bioventrix, a Delaware biotechnology corporation based in Mansfield, MA, is raising $3M under Regulation D exemption 6(b). The company has sold $1.2M to six investors so far with a $50K minimum and $1.8M remaining in the offering.

operating_company

Why now — by persona

  • Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock

People on the filing

Steven ChartierExecutive Officer, Director
Dave RichmondExecutive Officer, Director
Rishi PuriDirector
Mark RavichDirector
William AbrahamDirector

Signed by Molly Claire Benjamin, Account Administrator.

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.

Other filings by this issuer

32

BIOVENTRIX, INC. files Form D

Company raise update · Raising · Offering $12M · Sold $6.7M · MANSFIELD, MA · filed 2025-11-04
Placement agent engaged
25

BIOVENTRIX, INC. files Form D

Company raise update · Raising · Offering $7.5M · Sold $3.6M · MANSFIELD, MA · filed 2025-07-08
Placement agent engaged